Skip to Content

Gene signature of drug response in AD predicts drug repurpose in asthma

Asthma is common in patients initially diagnosed with atopic dermatitis (AD). Using gene signatures of drug responses in patients with AD is helping us to repurpose specific drugs for patients with severe asthma. In this MEDtalk, Professor Ian Adock elaborates this new approach, that can be applied across among more drugs and diseases.

Ian Adcock

Få tillgång till artikeln

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top